APNA Statements & Position Papers

APNA Organizational Responses and Endorsed Letters

Organizational Responses
APNA provides input and comments on issues that affect psychiatric mental health nursing. These responses generally are the product of collaboration between the membership, councils, and Board of Directors.

Endorsed Letters
APNA actively supports health care reform. To do so, we work with and through a number of coalitions. The Institute for Mental Health Advocacy reviews letters regarding pertinent legislative issues and determines whether or not we will endorse them.

APNA Position Papers - View All

Seclusion & Restraint Position Statement
Originally written in 2000, Revised in 2007, Revised April 2014.

Expansion of APRN Prescriptive Authority to Include Prescription of Buprenorphine & Buprenorphine/Naloxone (Suboxone)
Completed and released in July 2013.

Adoption of SBIRT in Psychiatric-Mental Health Nursing Practice
Completed and released in September 2012.

Position on LACE Recommendations
Position on LACE Recommendations
Position on LACE Recommendations

Position on LACE Recommendations
Completed and released in February 2011.

Electroconvulsive Therapy Position Statement
Completed and released in January 2011.

Psychiatric Mental Health Advanced Practice Nurses
Completed and released in October 2010.

Tobacco Dependence Position Statement
Completed and released in October 2008.

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.